Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01433302 · ClinicalTrials.gov registry record
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 21
- Enrollment target
NCT01433302: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01433302 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01433302 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to measure the amount of inflammatory proteins inside the body before and after lymphatico-venular bypass surgery. This will help doctors learn if anti-fibrotic or anti-inflammatory drugs/treatments given with the surgery can improve how well the surgery works.
Primary Outcome
5 mm punch biopsy specimens from the affected, lymphedematous limb will be obtained just prior to lymphatico-venular bypass and six (6) months after lymphatico-venular bypass. Punch biopsies will be obtained from the radial (lateral) aspect of the upper arm approximately 10cm above the olecranon process. Biopsy specimens will be collected from the contralateral (normal) arm at the exact same location.
Interventions
- PROCEDURE Punch Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-03 |
What the finished NCT01433302 record still lists
NCT01433302 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Punch Biopsy is the first listed.
NCT01433302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01433302 about?
NCT01433302 is a clinical study titled "Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass". The goal of this clinical research study is to measure the amount of inflammatory proteins inside the body before and after lymphatico-venular bypass surgery. This will help doctors learn if anti-fibrotic or anti-inflammatory drugs/treatments given with the surgery can improve how well the surgery w...
What is the current status of trial NCT01433302?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2012-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01433302?
The interventions under investigation include: Punch Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01433302?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia